低风险人群孕晚期小于胎龄儿筛查准确性对围产期不良结局的影响及生长轨迹指标的附加价值:IRIS研究的实用性二次分析
该研究为荷兰全国多中心阶梯楔形整群随机试验的二次分析,纳入11820例低风险孕妇,比较产前疑似与未疑似小于胎龄儿(SGA)新生儿的严重不良围产期结局(SAPO)和产科干预。真阳性SGA的SAPO风险aOR 4.46,假阴性aOR 2.61;假阳性与真阴性所有结局无差异。仅腹围增长速率Z评分<10%与SAPO中度相关(aOR 2.15),未支持孕晚期生长轨迹指标有附加价值。
要点
- 产前疑似SGA的真阳性新生儿SAPO风险aOR 4.46,假阴性aOR 2.61。
- 假阳性与真阴性所有结局无差异,包括产科干预。
- 仅ACGV<10%与SAPO中度相关(aOR 2.15),轨迹指标无附加价值。
核心结论
- 产前疑似SGA但出生为非SGA的新生儿,其产科干预率不高于产前未疑似SGA的新生儿。
- 结果不支持孕晚期低胎儿生长速度(ACGV<10%)对识别全程低风险人群中SAPO风险胎儿有附加价值。
- AC和EFW跨越>20百分位及AC跨越>50百分位在识别异常胎儿生长方面表现不佳。
研究设计与样本
- 荷兰全国多中心阶梯楔形整群随机试验(IRIS研究)的二次分析,纳入11820例低风险孕妇。
- 采用多水平多变量logistic回归分析,比较产前疑似与未疑似SGA新生儿的SAPO和产科干预。
- 亚样本(n=7989)分析AC和EFW<第10百分位(p10)及孕晚期生长轨迹指标与SAPO和产科干预的关联。
主要发现
- 真阳性SGA的SAPO风险aOR 4.46(95%CI 2.28-8.75),假阴性aOR 2.61(95%CI 1.74-3.89)。
- 真阳性SGA的引产aOR 2.99(95%CI 2.15-4.17),假阴性引产aOR 1.38(95%CI 1.14-1.66)。
- 真阳性SGA的剖宫产aOR 1.82(95%CI 1.25-2.66),假阴性剖宫产aOR 1.27(95%CI 1.05-1.54)。
- 真阳性SGA的医学指征早产aOR 2.67(95%CI 1.97-3.62),假阴性aOR 1.20(95%CI 1.03-1.40)。
- 仅ACGV<10%与SAPO中度相关(aOR 2.15,95%CI 1.17-3.97);单独EFW<p10(aOR 1.95,95%CI 1.13-3.38)及EFW<p10联合ACGV<10%(aOR 4.69,95%CI 1.99-11.07)与SAPO相关,两者预测SAPO的AUC分别为0.71(95%CI 0.65-0.76)和0.72(95%CI 0.67-0.77),P=0.51。
临床怎么用
- 原文结论未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To examine the implications of third-trimester small-for-gestational-age (SGA) screening accuracy on severe adverse perinatal outcome (SAPO) and obstetric intervention in a low-risk population. Furthermore, we aimed to explore the additive value of third-trimester sonographic growth-trajectory measurements in predicting SAPO and obstetric intervention. METHODS: This was a secondary analysis of a Dutch national multicenter stepped-wedge-cluster randomized trial among 11 820 low-risk pregnant women. Using multilevel multivariable logistic regression analysis, we compared SAPO and obstetric interventions in SGA neonates with and without SGA suspected prenatally (true positives and false negatives) and non-SGA neonates with and without SGA suspected prenatally (false positives and true negatives). In a subsample (n = 7989), we analyzed the associations of abdominal circumference (AC) and estimated fetal weight (EFW) < 10th centile (p10) and third-trimester growth-trajectory indicators AC and EFW crossing > 20 and AC crossing > 50 centiles and the lowest decile of AC growth-velocity Z-scores (ACGV < 10%) with SAPO and obstetric interventions. RESULTS: SGA infants, i.e. the true-positive and false-negative cases, had an increased risk of SAPO (adjusted odds ratio (aOR), 4.46 (95% CI, 2.28-8.75) and aOR 2.61 (95% CI, 1.74-3.89), respectively), and obstetric intervention (aOR for: induction of labor, 2.99 (95% CI, 2.15-4.17) and 1.38 (95% CI, 1.14-1.66); Cesarean section, 1.82 (95% CI, 1.25-2.66) and 1.27 (95% CI, 1.05-1.54); medically indicated preterm delivery, 2.67 (95% CI, 1.97-3.62) and 1.20 (95% CI, 1.03-1.40)). The false-positive cases did not differ from the true negatives for all outcomes, including obstetric intervention. Of the third-trimester growth-trajectory indicators, only ACGV < 10% was associated moderately with SAPO (aOR, 2.15 (95% CI, 1.17-3.97)), while AC and EFW crossing > 20 and AC crossing > 50 centiles were not. Both EFW < p10 alone (aOR, 1.95 (95% CI, 1.13-3.38)) and EFW < p10 combined with ACGV < 10% (aOR, 4.69 (95% CI, 1.99-11.07)) were associated with SAPO, and they performed equally well in predicting SAPO (area under the receiver-operating-characteristics curve, 0.71 (95% CI, 0.65-0.76) vs 0.72 (95% CI, 0.67-0.77), P = 0.51). CONCLUSION: Neonates who had been suspected falsely of being SGA during pregnancy had no higher rates of obstetric intervention than did those without suspicion of SGA prenatally. Our results do not support that third-trimester low fetal growth velocity (ACGV < 10%) may be of additive value for the identification of fetuses at risk of SAPO in populations remaining at low risk throughout pregnancy. AC and EFW crossing > 20 and AC crossing > 50 centiles performed poorly in identifying abnormal fetal growth. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- van Roekel M, Henrichs J, Franx A, et al. Implication of third-trimester screening accuracy for small-for-gestational age and additive value of third-trimester growth-trajectory indicators in predicting severe adverse perinatal outcome in low-risk population: pragmatic secondary analysis of IRIS study. Ultrasound Obstet Gynecol. 2023. PMID: 36704993. doi:10.1002/uog.26167
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。